Biotech | October 19, 2021
Vertex’s stem cell therapy for Type 1 diabetes reduced daily insulin requirement by 91 %
The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit
